Oncopeptides AB (publ) (STO:ONCO)
Sweden · Delayed Price · Currency is SEK 2.500
+0.196 (8.51%)
Sep 25, 2026, 5:29 PM CET
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of 988.22 million as of September 25, 2026. Its market cap has decreased by -21.82% in one year.
Market Cap
988.22M
Enterprise Value
965.78M
Revenue
95.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.50
ChartMarket Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 1.67B to 988.22M, a decrease of -40.81%. That is a compound annual growth rate of -5.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 988.22M | -24.58% |
| Dec 30, 2025 | 1.31B | 291.35% |
| Dec 30, 2024 | 334.83M | -53.79% |
| Dec 29, 2023 | 724.64M | -36.76% |
| Dec 30, 2022 | 1.15B | 81.18% |
| Dec 30, 2021 | 632.45M | -94.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Flerie AB | 1.49B |
| BioInvent International AB | 1.46B |
| Saniona AB | 1.34B |
| Genovis AB (publ.) | 1.28B |
| AlzeCure Pharma AB | 1.03B |
| Medivir AB | 1.00B |
| SynAct Pharma AB | 968.77M |
| Infant Bacterial Therapeutics AB | 917.40M |